Laminin-5 γ2 chain immunohistochemistry facilitates the assessment of invasiveness and improves the diagnostic reproducibility of glandular lesions of the cervix uteri

Human Pathology

Volumn 37, Issue 6, 2006, Pages 704-710

  Negri, Giovanni ^a   Romano, Fabio ^a   Vittadello, Fabio ^a   Kasal, Armin ^a   Mazzoleni, Guido ^a   Colombetti, Vito ^a   Egarter Vigl, Eduard ^a  

^a CENTRAL HOSPITAL OF BOLZANO   (Italy)

Author keywords

Adenocarcinoma; AIS; Immunohistochemistry; Laminin; Uterine cervix

Indexed keywords

EOSIN; HEMATOXYLIN; KALININ; LAMININ 5 GAMMA2; UNCLASSIFIED DRUG; CELL ADHESION MOLECULE;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INVASION; CARCINOMA IN SITU; CELL INFILTRATION; CONTROLLED STUDY; CYTOPLASM; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KAPPA STATISTICS; MAJOR CLINICAL STUDY; OVARY ADENOCARCINOMA; PROTEIN EXPRESSION; REPRODUCIBILITY; UTERINE CERVIX CARCINOMA; ADENOCARCINOMA; METABOLISM; PATHOLOGY; UTERINE CERVIX TUMOR;

ADENOCARCINOMA; CELL ADHESION MOLECULES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM INVASIVENESS; REPRODUCIBILITY OF RESULTS; UTERINE CERVICAL NEOPLASMS;

EID: 33745452920     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2006.01.020     Document Type: Article

References (23)

1. Vizcaino A.P., Moreno V., Bosch F.X., et al. International trends in the incidence of cervical cancer: adenocarcinoma and adenosquamous cell carcinomas. Int J Cancer 75 (1998) 536-545
2. Wells M., Östor A.G., Crum C.P., et al. Tumours of the uterine cervix. Epithelial tumours. In: Tavassoli F.A., and Devilee P. (Eds). Tumours of the breast and female genital organs (2003), IARC press 262
3. Alfsen G.C., Reed W., and Abeler V.M. Reproducibility of classification in non-squamous cell carcinomas of the uterine cervix. Gynecol Oncol 90 (2003) 282-289
4. Ostor A.G. Early invasive adenocarcinoma of the uterine cervix. Int J Gynecol Pathol 19 (2000) 29-38
5. Katayama M., and Sekiguchi K. Laminin-5 in epithelial tumour invasion. J Mol Histol 35 (2004) 277-286
6. Lohi J. Laminin-5 in the progression of carcinomas. Int J Cancer 94 (2001) 763-767
7. Giannelli G., and Antonaci S. Biological and clinical relevance of laminin-5 in cancer. Clin Exp Metastasis 18 (2000) 439-443
8. Koshikawa N., Giannelli G., Cirulli V., et al. Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5. J Cell Biol 148 (2000) 615-624
9. Maatta M., Soini Y., Paakko P., et al. Expression of the laminin gamma2 chain in different histological types of lung carcinoma. A study by immunohistochemistry and in situ hybridization. J Pathol 188 (1999) 361-368
10. Moriya Y., Niki T., Yamada T., et al. Increased expression of laminin-5 and its prognostic significance in lung adenocarcinomas of small size. An immunohistochemical analysis of 102 cases. Cancer 91 (2001) 1129-1141
11. Shinto E., Tsuda H., Ueno H., et al. Prognostic implication of laminin-5 gamma 2 chain expression in the invasive front of colorectal cancers, disclosed by area-specific four-point tissue microarrays. Lab Invest 85 (2005) 257-266
12. Nilsson P.J., Rubio C., Lenander C., et al. Tumour budding detected by laminin-5 {gamma}2-chain immunohistochemistry is of prognostic value in epidermoid anal cancer. Ann Oncol 16 (2005) 893-898
13. Koshikawa N., Moriyama K., Takamura H., et al. Overexpression of laminin gamma2 chain monomer in invading gastric carcinoma cells. Cancer Res 59 (1999) 5596-5601
14. Hindermann W., Berndt A., Haas K.M., et al. Immunohistochemical demonstration of the gamma2 chain of laminin-5 in urinary bladder urothelial carcinoma. Impact for diagnosis and prognosis. Cancer Detect Prev 27 (2003) 109-115
15. Kiyoshima K., Oda Y., Kinukawa N., et al. Overexpression of laminin-5 gamma2 chain and its prognostic significance in urothelial carcinoma of urinary bladder: association with expression of cyclooxygenase 2, epidermal growth factor, and human epidermal growth factor 2. Hum Pathol 36 (2005) 522-530
16. Kohlberger P., Beneder Ch., Horvat R., et al. Immunohistochemical expression of laminin-5 in cervical intraepithelial neoplasia. Gynecol Oncol 89 (2003) 391-394
17. Skyldberg B., Salo S., Eriksson E., et al. Laminin-5 as a marker of invasiveness in cervical lesions. J Natl Cancer Inst 91 (1999) 1882-1887
18. Stoltzfus P., Salo S., Eriksson E., et al. Laminin-5 gamma2 chain expression facilitates detection of invasive squamous cell carcinoma of the uterine cervix. Int J Gynecol Pathol 23 (2004) 215-222
19. Fleiss J.L., Nee C.M., and Landis J.R. Large sample variance of kappa in the case of different sets of raters. Psychol Bull 86 (1979) 974-977
20. Fleiss J.L. Statistical methods for rates and proportions. 2nd ed. (1981), John Wiley and Sons, New York 222
21. Kohlberger P., Muller-Klingspor V., Heinzl H., et al. Prognostic value of laminin-5 in serous adenocarcinomas of the ovary. Anticancer Res 22 (2002) 3541-3544
22. Yamamoto H., Itoh F., Iku S., et al. Expression of the gamma(2) chain of laminin-5 at the invasive front is associated with recurrence and poor prognosis in human esophageal squamous cell carcinoma. Clin Cancer Res 7 (2001) 896-900
23. Ostor A., Rome R., and Quinn M. Microinvasive adenocarcinoma of the cervix: a clinicopathologic study of 77 women. Obstet Gynecol 89 (1997) 88-93